Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sage Therapeutics

6.70
+0.10001.52%
Post-market: 6.900.1999+2.98%19:14 EDT
Volume:647.39K
Turnover:4.31M
Market Cap:419.56M
PE:-1.16
High:6.72
Open:6.52
Low:6.44
Close:6.60
Loading ...

Sage Therapeutics price target raised to $9 from $6 at Mizuho

TIPRANKS
·
30 Jan

SAGE Therapeutics (SAGE) Gets a Hold from Mizuho Securities

TIPRANKS
·
30 Jan

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates

Zacks
·
30 Jan

SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up

Zacks
·
29 Jan

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires Live
·
28 Jan

Update: Sage Therapeutics Board Rejects Biogen's Unsolicited Acquisition Bid

MT Newswires Live
·
28 Jan

BUZZ-Sage Therapeutics rises after rejecting Biogen's $469 mln acquisition offer

Reuters
·
27 Jan

SAGE Therapeutics Board Rejects Biogen's Unsolicited Acquisition Bid

MT Newswires Live
·
27 Jan

Sage Rejects Biogen Bid, Launches Review of Alternatives

Dow Jones
·
27 Jan

Sage rejects Biogen's $469 million takeover offer, says offer undervalues company

Reuters
·
27 Jan

Sage rejects Biogen's takeover offer, to explore strategic alternatives

Reuters
·
27 Jan

BRIEF-Sage Therapeutics Rejects Biogen's $7.22 Per Share Acquisition Proposal

Reuters
·
27 Jan

Sage Therapeutics Inc - Concludes Proposal From Biogen Significantly Undervalues Co

THOMSON REUTERS
·
27 Jan

Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal

THOMSON REUTERS
·
27 Jan

Wedbush Raises Price Target on SAGE Therapeutics to $6 From $4, Keeps Neutral Rating

MT Newswires Live
·
23 Jan

RBC Capital Remains a Hold on SAGE Therapeutics (SAGE)

TIPRANKS
·
23 Jan

TD Cowen Keeps Their Hold Rating on SAGE Therapeutics (SAGE)

TIPRANKS
·
21 Jan

Scotiabank Remains a Buy on SAGE Therapeutics (SAGE)

TIPRANKS
·
21 Jan

Biotech Stock Roundup: MRNA, NTLA Down on Updates, SAGE Up on Biogen's Offer & Other Updates

Zacks
·
17 Jan

Biogen CEO sees no burning need for more acquisitions

Reuters
·
15 Jan